133 related articles for article (PubMed ID: 16878285)
1. [A new breath actuated dry powder inhaler (Auto-Jethaler)].
Steiss JO; Heckmann M; Jödicke B; Landmann E; Schüler D; Weber K; Pabst J; Lindemann H
Klin Padiatr; 2007; 219(2):66-9. PubMed ID: 16878285
[TBL] [Abstract][Full Text] [Related]
2. Variation of peak inspiratory flow through dry powder inhalers in children with stable and unstable asthma.
Kamps AW; Brand PL; Roorda RJ
Pediatr Pulmonol; 2004 Jan; 37(1):65-70. PubMed ID: 14679492
[TBL] [Abstract][Full Text] [Related]
3. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.
Amirav I; Newhouse MT; Mansour Y
Pediatr Pulmonol; 2005 May; 39(5):447-51. PubMed ID: 15765541
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of inspiratory flow-volume curves in children with bronchial asthma and patients with cystic fibrosis].
Holmann JC; Schibler A; Kraemer R
Schweiz Med Wochenschr; 1989 Dec; 119(48):1713-8. PubMed ID: 2617276
[TBL] [Abstract][Full Text] [Related]
5. Stability and performance characteristics of a budesonide powder for inhalation with a novel dry powder inhaler device.
Fyrnys B; Stang N; Wolf-Heuss E
Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S7-11. PubMed ID: 11385814
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of breath actuated devices in asthmatic children with bronchial obstruction].
Tomalak W; Doniec Z
Wiad Lek; 2006; 59(1-2):61-5. PubMed ID: 16646295
[TBL] [Abstract][Full Text] [Related]
7. Inspiratory flow rate through a dry powder inhaler (Clickhaler) in children with asthma.
Parry-Billings M; Birrell C; Oldham L; O'Callaghan C
Pediatr Pulmonol; 2003 Mar; 35(3):220-6. PubMed ID: 12567391
[TBL] [Abstract][Full Text] [Related]
8. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
9. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD.
Schulte M; Osseiran K; Betz R; Wencker M; Brand P; Meyer T; Haidl P
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):321-8. PubMed ID: 18823257
[TBL] [Abstract][Full Text] [Related]
10. [The evaluation of useful breath actuated inhalers by preschool asthmatic children].
Doniec Z; Kurzawa R; Jedrys-Kłucjasz U; Pisiewicz K; Mazurek E; Widerska-Kurzawa A
Pol Merkur Lekarski; 2005 Apr; 18(106):389-92. PubMed ID: 16161917
[TBL] [Abstract][Full Text] [Related]
11. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler).
Engel T; Heinig JH; Madsen F; Nikander K
Eur Respir J; 1990 Oct; 3(9):1037-41. PubMed ID: 2289551
[TBL] [Abstract][Full Text] [Related]
12. [Peak inspiratory flow using 2 different inhalers and a new portable device].
García-Marcos Alvarez L; Martínez Torres A; Guillén Pérez JJ; Martínez Victoria A
An Esp Pediatr; 2001 Feb; 54(2):110-3. PubMed ID: 11181205
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalers.
de Boer AH; Gjaltema D; Hagedoorn P; Frijlink HW
Pharmazie; 2004 Sep; 59(9):692-9. PubMed ID: 15497751
[TBL] [Abstract][Full Text] [Related]
14. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
15. Measurement of inspiratory flow in children with acute asthma.
Bentur L; Mansour Y; Hamzani Y; Beck R; Elias N; Amirav I
Pediatr Pulmonol; 2004 Oct; 38(4):304-7. PubMed ID: 15334507
[TBL] [Abstract][Full Text] [Related]
16. Novolizer: the new technology for the management of asthma therapy.
Köhler D
Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S11-6. PubMed ID: 12974537
[TBL] [Abstract][Full Text] [Related]
17. Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older.
Tiddens HA; Geller DE; Challoner P; Speirs RJ; Kesser KC; Overbeek SE; Humble D; Shrewsbury SB; Standaert TA
J Aerosol Med; 2006; 19(4):456-65. PubMed ID: 17196074
[TBL] [Abstract][Full Text] [Related]
18. Dry powder inhalers: which factors determine the frequency of handling errors?
Wieshammer S; Dreyhaupt J
Respiration; 2008; 75(1):18-25. PubMed ID: 17911976
[TBL] [Abstract][Full Text] [Related]
19. Do patients think that dry powder inhalers can be used interchangeably?
Booker R
Int J Clin Pract Suppl; 2005 Dec; (149):30-2. PubMed ID: 16280001
[TBL] [Abstract][Full Text] [Related]
20. [Teaching the inhalation manoeuvre to asthmatic children by means of visual feedback].
Kamin W; Kreplin A
Pneumologie; 2007 Mar; 61(3):150-6. PubMed ID: 17342574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
